» Articles » PMID: 28256516

SwissADME: a Free Web Tool to Evaluate Pharmacokinetics, Drug-likeness and Medicinal Chemistry Friendliness of Small Molecules

Overview
Journal Sci Rep
Specialty Science
Date 2017 Mar 4
PMID 28256516
Citations 3600
Authors
Affiliations
Soon will be listed here.
Abstract

To be effective as a drug, a potent molecule must reach its target in the body in sufficient concentration, and stay there in a bioactive form long enough for the expected biologic events to occur. Drug development involves assessment of absorption, distribution, metabolism and excretion (ADME) increasingly earlier in the discovery process, at a stage when considered compounds are numerous but access to the physical samples is limited. In that context, computer models constitute valid alternatives to experiments. Here, we present the new SwissADME web tool that gives free access to a pool of fast yet robust predictive models for physicochemical properties, pharmacokinetics, drug-likeness and medicinal chemistry friendliness, among which in-house proficient methods such as the BOILED-Egg, iLOGP and Bioavailability Radar. Easy efficient input and interpretation are ensured thanks to a user-friendly interface through the login-free website http://www.swissadme.ch. Specialists, but also nonexpert in cheminformatics or computational chemistry can predict rapidly key parameters for a collection of molecules to support their drug discovery endeavours.

Citing Articles

Comprehensive overview of the toxicities of small-molecule cryoprotectants for carnivorous spermatozoa: foundation for computational cryobiotechnology.

Karimi I, Mohammad L, Suvitha A, Haidari Z, Schioth H Front Toxicol. 2025; 7:1477822.

PMID: 40078955 PMC: 11897285. DOI: 10.3389/ftox.2025.1477822.


Revealing Lingonberry's Neuroprotective Potential in Alzheimer's Disease Through Network Pharmacology and Molecular Docking.

Li J, Wang M, Wang Y, Peng X, Lv G, Zheng T Int J Mol Sci. 2025; 26(5).

PMID: 40076984 PMC: 11899733. DOI: 10.3390/ijms26052363.


Panduratin A from Effectively Inhibits EGFR/STAT3/Akt Signaling Pathways, Inducing Apoptosis in NSCLC Cells with Wild-Type and T790M Mutations in EGFR.

Eiamart W, Wonganan P, Tadtong S, Samee W Int J Mol Sci. 2025; 26(5).

PMID: 40076971 PMC: 11900324. DOI: 10.3390/ijms26052350.


Design and Synthesis of New 5-Methylisatin Derivatives as Potential CDK2 Inhibitors.

Czelen P, Skotnicka A, Szefler B, Kabatc-Borcz J, Sutkowy P Int J Mol Sci. 2025; 26(5).

PMID: 40076766 PMC: 11900410. DOI: 10.3390/ijms26052144.


Rational Design and Optimization of Novel PDE5 Inhibitors for Targeted Colorectal Cancer Therapy: An In Silico Approach.

Oladeji S, Conteh D, Bello L, Adegboyega A, Shokunbi O Int J Mol Sci. 2025; 26(5).

PMID: 40076563 PMC: 11899891. DOI: 10.3390/ijms26051937.


References
1.
Baell J, Holloway G . New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem. 2010; 53(7):2719-40. DOI: 10.1021/jm901137j. View

2.
Sharom F . ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics. 2007; 9(1):105-27. DOI: 10.2217/14622416.9.1.105. View

3.
Kirchmair J, Goller A, Lang D, Kunze J, Testa B, Wilson I . Predicting drug metabolism: experiment and/or computation?. Nat Rev Drug Discov. 2015; 14(6):387-404. DOI: 10.1038/nrd4581. View

4.
Di L . The role of drug metabolizing enzymes in clearance. Expert Opin Drug Metab Toxicol. 2014; 10(3):379-93. DOI: 10.1517/17425255.2014.876006. View

5.
Szakacs G, Varadi A, Ozvegy-Laczka C, Sarkadi B . The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Discov Today. 2008; 13(9-10):379-93. DOI: 10.1016/j.drudis.2007.12.010. View